Skip to main content
Recent demonstration of an effective treatment for night eating syndrome (1) argues for wider recognition of the disorder to benefit the many persons who suffer from it. These include 1.1%–1.5% of the general population, 6%–16% of patients in weight reduction programs, and 8%–42% of candidates for bariatric surgery. Viewed as a delay in the circadian rhythm of food intake, night eating syndrome is defined by two core criteria: evening hyperphagia (ingestion of at least 25% of daily calories after supper) and/or awakenings with ingestions at least three times a week. These criteria have identified persons whose behavior manifests a coherent biobehavioral model of night eating syndrome, supporting its construct validity. Single photon emission computed tomography has shown significant elevation of serotonin transporters in the midbrain of night eaters (2) . This elevation may result from a genetic vulnerability transmitted as part of the established heritability of night eating syndrome (3), which is triggered by the stress that night eaters report. Elevations in serotonin transporter levels lead to decreased postsynaptic serotonin transmission and should impair circadian rhythms and satiety. These deficits suggest that improvement in serotonin function should alleviate night eating syndrome, and the selective serotonin reuptake inhibitors do precisely that. Reports of response to paroxetine and fluvoxamine have been accompanied by two larger open-label trials with a strong response to sertraline. Finally, a placebo-controlled, double-blind study of sertraline showed significant improvements in both of the criteria for night eating syndrome (1) .
Night eating may be a pathway to obesity; it preceded the onset of obesity in three studies and predicted major weight gain among female night eaters who were already obese (4) . Five animal models, each of a different etiology, have also shown a circadian dysrhythmia with hyperphagia and obesity. In addition to its contribution to weight gain, night eating syndrome is a source of distress, making it worthy of treatment for its own sake.

Footnotes

Address correspondence and reprint requests to Dr. Stunkard, Center for Weight and Eating Disorders, Department of Psychiatry, University of Pennsylvania School of Medicine, 3535 Market St., Suite 3025, Philadelphia, PA 19104-3309; [email protected] (e-mail). Editorial accepted for publication October 2007 (doi: 10.1176/appi.ajp.2007.07081351).
The authors report no competing interests.

References

1.
O’Reardon JP, Allison KC, Martino NS, Lundgren JD, Heo M, Stunkard AJ: A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome. Am J Psychiatry 2006; 163:893–898
2.
Lundgren JD, Newberg A, Allison KC, Wintering N, Ploessl K, Stunkard AJ: 123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: a pilot study. Psychiatry Res (in press)
3.
Lundgren JD, Allison KC, Stunkard AJ: Familial aggregation in the night eating syndrome. Int J Eat Disord 2006; 39:516–518
4.
Andersen GS, Stunkard AJ, Sørensen TI, Petersen L, Heitmann BL: Night eating and weight change in middle-aged men and women. Int J Obes Relat Metab Disord 2004; 28:1338–1343

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 424
PubMed: 18381912

History

Published online: 1 April 2008
Published in print: April, 2008

Authors

Details

Jennifer Lundgren, Ph.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share